Rekombinanter EGFR (Nimotuzumab Biosimilar) Antikörper
Reaktivität: Human
BR, FACS, IHC
Wirt: Human
Monoclonal
H-R3
unconjugated
Recombinant Antibody
-
- Target Alle EGFR (Nimotuzumab Biosimilar) Produkte
- EGFR (Nimotuzumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
-
Wirt
-
Human
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser EGFR (Nimotuzumab Biosimilar) Antikörper ist unkonjugiert
- Applikation
- Blocking Reagent (BR), Flow Cytometry (FACS), Immunohistochemistry (IHC)
- Produktmerkmale
-
Original Species of Ab: Human
Original Format of Ab: IgG1
- Aufreinigung
- Purified antibody.
- Immunogen
- This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors.
- Klon
- H-R3
- Isotyp
- IgG1 kappa
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- EGFR (Nimotuzumab Biosimilar)
- Abstract
- EGFR (Nimotuzumab Biosimilar) Produkte
- Substanzklasse
- Biosimilar
- Hintergrund
- ERBB-D3, ERBB1, HER1, PIG61, mENA, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1, epidermal growth factor
- UniProt
- P00533
-
Sie sind hier:
